Commercial fleets face potential disruptions from recalls affecting emergency stops, oil leaks, and safety system ...

The software team at General Motors has now lost three top executives in the past month as the automaker — with its new chief product officer at the helm — combines its disparate technology businesses ...

GM confirmed Cetinok’s departure to the Detroit Free Press on Nov. 26. GM placed big bets on the California-based tech experts that worked from the company’s Mountain View offices to revolutionize its ...

This story was originally published on WardsAuto. To receive daily news and insights, subscribe to our free daily WardsAuto newsletter. Former Apple executive Baris Cetinok, who currently serves as ...

Baris Cetinok is the latest Silicon Valley alum to leave General Motors Co., a spokesperson for the Detroit automaker confirmed Tuesday. Cetinok joined the company in 2023 and most recently served as ...

GM faces another significant departure from its technology leadership ranks as Baris Cetinok, Senior Vice President of Software and Services Product Management, submits his resignation. CNBC reports ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

The Detroit Free Press reports that GM is reshuffling its technology leadership, as Chief Artificial Intelligence Officer Barak Turovsky has departed the company after just eight months in the role, ...

Bariş Cetinok, General Motors’ senior vice president of software and services product management, has left the Detroit automaker, the third former Silicon Valley exec to depart in less than a month.

Cancer immunotherapy has proven efficacy in some cancer subtypes but it often fails to deliver clinically meaningful benefits to patients because their tumors are poorly immunogenic. A major goal of ...

The biotech firm’s polyclonal anti-cancer therapy is based on an ex vivo approach and avoids the use of toxic immune-depleting chemotherapy. Rapa Therapeutics (Rapa) is bringing the power of ...